Essling Capital

Teknimed is a French manufacturer of implantable biomaterials and related delivery systems for orthopedics, spine, and sports medicine. It designs, develops, and manufactures synthetic bone substitutes, orthopedic and vertebroplasty cements, resorbable polymers, resorbable ligaments, and ancillary mixing or delivery devices, serving a global distributor network. The company specializes in calcium phosphates, PMMA bone cements, textiles, and instrumentation, and applies processes such as sintering, injection, lyophilisation, and chemical synthesis. Based in Vic-en-Bigorre, Teknimed operates with multiple clean rooms and dedicated R&D, quality control, and packaging facilities to support innovation and quality in surgical biomaterials.

Ubi Transport SAS is a technology company specializing in software solutions for the passenger transportation sector. Founded in 2012 and headquartered in Macon, France, with additional offices in Cagnes-sur-Mer, Paris, Chicago, and Montreal, Ubi Transport develops cloud-based platforms that enhance various aspects of transportation management. Their offerings include 2Cloud for data management, 2Place for passenger information systems, 2School for student transportation management, 2Tod for trip booking and dispatching, and 2PlaceJob for employee transport. The company also provides mobile data terminals for drivers and travel cards for passenger validation. Ubi Transport's solutions are designed to facilitate real-time information sharing among drivers, operators, communities, and users, thereby promoting efficiency in school, intercity, urban, and on-demand transport services. Through innovative and agile digital solutions, Ubi Transport has significantly advanced everyday mobility since its inception.